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2001; Samelson, 2002). One important process is TCR-
induced activation of diverse serine/threonine kinases.
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lus (Matthews et al., 2003; Rey et al., 2003a, 2003b;
Sturany et al., 2002; Van Lint et al., 2002). PKD1 is mostProtein kinase D (PKD) is an antigen receptor-acti-
abundant in hematopoietic cells and is the predominantvated serine kinase localized at either the plasma
PKD isoform expressed in T cells (U.M. and Thomasmembrane or the cytosol of lymphocytes. To probe
Seufferlein, unpublished data). PKDs are characterizedPKD function at these different locations, transgenesis
by a conserved high-affinity diacyglycerol (DAG) bindingwas used to target active PKD either to the membrane
cysteine-rich domain (CRD) which controls the intracel-or cytosol of pre-T cells. In recombinase gene null
lular localization of the enzyme (Matthews et al., 1999a,pre-T cells, membrane and cytosolic active PKD both
2000a). PKD is strongly activated by antigen receptorinduced differentiation reminiscent of  selection:
stimulation in T cells, B cells, and mast cells (Matthewsdownregulation of CD25 and upregulation of CD2 and
et al., 2000a, 2000b). The activation of PKDs requiresCD5. Active PKDs also induced pre-T cell proliferation,
phosphorylation of two key serine residues, Ser744 andalthough this response was not universal to all thymo-
Ser748, within the activation loop of the catalytic domaincyte subsets. There were two striking differences be-
(Iglesias et al., 1998; Waldron et al., 2001). These phos-tween the actions of the differentially localized PKDs.
phorylations are mediated by serine kinases of the PKCMembrane but not cytosolic PKD could induce expres-
family so that PKD is positioned to act as an effector ofsion of CD8 and CD4 in recombinase null mice; cyto-
PKC (Matthews et al., 2000b; Waldron et al., 1999). PKDsolic but not membrane PKD suppressed V to DJ
activity is thus mediated by phospholipase Cs (PLC) whichrearrangements of the TCR chain locus in wild-type
hydrolyze phosphatidylinositol(4,5)P2 (PtdIns(4,5)P2) pro-T cells. PKD function is thus determined by its intracel-
ducing DAG, which regulates intracellular localizationlular location and cell context.
and activity of PKCs.
Of particular interest is the spatial/temporal analysisIntroduction
of PKD activation. Antigen receptors induce a rapid and
transient translocation of PKD to the plasma membrane
The T cell antigen receptor (TCR) is the key regulator of
(Matthews et al., 1999a, 2000a). During sustained re-
peripheral T cell function (Kruisbeek et al., 2000; Michie sponses to antigen receptor engagement, PKD relo-
and Zuniga-Pflucker, 2002; von Boehmer et al., 1999). cates to the cytosol where it remains active for several
The / subunits of the TCR are formed by a recombina- hours. PKD can thus transduce a signal generated at
tion process in the thymi; the first step is rearrangement the plasma membrane into a sustained signal in the cell
of the TCR locus which, if productive, results in surface interior. In fibroblasts, PKD also shuttles between the
expression of the pre-TCR receptor complex. The ex- plasma membrane and the cytosol (Rey et al., 2001a,
pression of a functional pre-TCR induces a proliferation 2001b, 2003a, 2003b). Most studies of PKD function to
and differentiation program known as  selection date have been in HeLa cells where PKD localizes to
marked by expression of the coreceptors for major his- the Golgi and have been described to regulate Golgi
tocompatibilty molecules, CD4 and CD8. Thymocytes function (Baron and Malhotra, 2002; Hausser et al., 2002;
that are  chain-selected rearrange their TCR locus, Jamora et al., 1999; Liljedahl et al., 2001; Rey and Ro-
express a mature TCR, and are selected to either CD4 zengurt, 2001). PKD has also been shown to contribute
or CD8 single-positive T cells. to NFB activation in response to oxidative stress in
The importance of antigen receptors for T cell biology HeLa cells (Storz and Toker, 2003). It has been proposed
has created much interest in the signaling pathways that PKD function will be cell context dependent and
this receptor uses (Cantrell, 2002; Koretzky and Myung, may be dependent on where the enzyme is localized
inside the cell (Hurd and Rozengurt, 2003; Van Lint et
al., 2002).*Correspondence: d.a.cantrell@dundee.ac.uk
Immunity
492
A key issue for PKD in T cells is whether membrane establish that T cell progenitors express endogenous
PKD and regulate it by physiological stimulus. Early thy-and cytosol localized PKD have different functions. The
way to probe the role of PKD in different intracellular mocyte progenitors lack expression of CD4 and CD8
(CD4CD8 double-negatives [DNs]). They can be sub-compartments is to design genetic strategies to target
active PKD mutants to different positions in a relevant divided further into subpopulations DN1–DN4 based on
the expression of CD44 and CD25 (Figure 2A) (KruisbeekT cell population. In these experiments, the use of “gain
of function” alleles of PKD is essential because these et al., 2000; Michie and Zuniga-Pflucker, 2002; von
Boehmer et al., 1999). Figure 2B shows that PKD ismake it possible to assess the functional downstream
consequences of activating PKD without simultaneous expressed in both DN3 and DN4 T cells at a level similar
to mature T cells (SP4). The pan-PKD antibody used intriggering of other signaling molecules. In the present
work, the human CD2 promoter and locus control region these experiments would equally recognize PKD1 and
PKD2. However, Western blot analysis with PKD2-spe-(CD2-LCR) (Zhumabekov et al., 1995) was used to ex-
press either cytosol or membrane targeted active mu- cific antisera (Sturany et al., 2001) failed to find expres-
sion of PKD2 in the thymus (data not shown).tants of PKD in T cells of transgenic mice. This trans-
genic vector initiates expression in early pre-T cells and To examine the ability of the pre-TCR to activate PKD,
thymocytes were isolated from mice deficient in recom-is a perfect vehicle to probe the immediate conse-
quences of PKD activation for pre-TCR functions. This binase-activating gene 2 (RAG2/). These mice are de-
fective in antigen receptor gene rearrangements and areantigen receptor complex controls a key stage of T cell
development, and pre-T cells are a good system for blocked at the DN3 stage of thymocyte development
(Godfrey et al., 1994; Shinkai et al., 1992). RAG2/ DN3sfunctional analysis of antigen receptor signaling path-
ways in primary cells. The present data reveal that mem- express low levels of CD3, and crosslinking of CD3 syn-
chronously mimics the signaling events of the pre-TCRbrane localized and cystolic PKD have different func-
tions in pre-T cells. The data also show that the actions (Jacobs et al., 1994; Shinkai and Alt, 1994). Figure 2C
shows that CD3 crosslinking of RAG2/ DN3s inducesof PKD are cell context dependent and this enzyme can
control diverse responses in different cell populations. rapid and sustained increase in PKD catalytic activity.
PKD is thus expressed in pre-T cells and is activated
by the pre-TCR.Results
Generation of Active PKD Mutants Targeted Generation of T Cell-Specific Transgenic Mice
to the Plasma Membrane or the Cytosol Expressing Membrane Targeted Active PKD
An active PKD mutant that localized to the cytosol (cy- The CD2-LCR was used to express membPKD in the
toPKD) comprises the catalytic core of PKD (amino acids thymus (Figure 3). Two founder lines were established
559–918) and was generated by deleting the N-terminal that had identical phenotypes; for simplicity, data for
regions containing the DAG binding domain responsible one line is shown. FACS analysis confirmed that
for membrane targeting of the enzyme in lymphocytes membPKD was expressed in DN2 and DN3 cells and in
(Matthews et al., 1999a, 2000a). Active PKD was tar- all subsequent T cell developmental stages (Figure 3B
geted to the plasma membrane by fusing the catalytic and data not shown). MembPKD is active in thymocytes
core of PKD to the extracellular and transmembrane as judged by its autophosphorylation on S916 (Figure 3C).
domain of the cell surface receptor rat CD2 (rCD2) to There was no dramatic phenotype caused by expres-
create a rCD2-PKDcat chimera (membPKD). This chi- sion of membPKD. Thymocyte numbers were in the nor-
mera strategy has previously been successfully used to mal range, all thymocyte subsets were present although
membrane target enzymes (Reif et al., 1996). there was a subtle increase in the percentage of DNs
Western blots of transiently transfected lymphocytes and mild perturbation of TCR expression (Figure 3D). In
using an antisera recognizing PKD molecules autophos- a normal thymus there is a major population of cells
phorylated on S916 (Matthews et al., 1999b) show that with low levels of TCR corresponding to DPs and a
endogenous PKD and GFP-tagged PKDwt are active in smaller cell population with high TCR levels correspond-
phorbol ester (PdBu)-stimulated but not quiescent cells ing to SPs. In membPKD mice there was a discernable
while cytoPKD and membPKD were substantially active upregulation of TCR levels in the population correspond-
already in unstimulated cells (Figure 1B). Figure 1C ing to DPs (Figure 3D).
shows cytoPKD to be exclusively localized to the cyto- Frequently, the functional capacity of an active signal-
plasm. The expression of membPKD at the plasma mem- ing molecule is not uncovered until it is expressed on a
brane was determined by staining for cell surface expres- genetic background deficient in an upstream activator. In
sion of rCD2 followed by FACS analysis (Figure 1D). this context, PKD is expressed in pre-T cells and normally
activated by the pre-TCR (Figure 2). Accordingly, we
decided to analyze membPKD actions in pre-T cellsPKD Is Expressed in Pre-T Cells and Activated
by the Pre-TCR lacking a pre-TCR complex. One such model is recombi-
nase-activating gene null (RAG1/ or RAG2/) miceTo probe the function of cytoPKD and membPKD in
vivo, it was decided to use the CD2-LCR to drive PKD that are defective in antigen receptor rearrangements
and blocked at the DN3 stage of T cell developmentexpression in early T cell progenitors and all subsequent
stages of T cell development (Zhumabekov et al., 1995). (Godfrey et al., 1994; Mombaerts et al., 1992; Shinkai
et al., 1992). The membPKD transgene was expressedPKD is expressed in mature T cells and selectively acti-
vated by TCR stimulation (Matthews et al., 2000b). Prior on a RAG2/ genetic background by backcrossing
membPKD mice with RAG2/ mice. The ability of PKDto generating PKD transgenic mice, it was important to
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Figure 1. Construction of Membrane Targeted and Cytoplasmic Active PKD
(A) Schematic picture of full-length PKD (PKDwt) and active PKD derivatives targeted to the cytosol (cytoPKD) or plasma membrane (membPKD).
The catalytic domain of PKD (aa 559–918) was fused to GFP to create GFP-cytoPKD or to the rCD2 chimera to generate membPKD.
(B) A20 cells were transiently transfected with the indicated PKD expression constructs. Cells were harvested 16 hr posttransfection and
either left unstimulated () or stimulated with PdBu (), and PKD activity in intact cells was detected by immunoblotting using a p916 antiserum
(-p916, upper panel). Membranes were stripped and reprobed with pan-PKD antiserum (-PKD, lower panel) to monitor PKD expression
levels. Arrows indicate endogenous PKD (ePKD), GFP-PKDwt, GFP-cytoPKD, and membPKD.
(C) Confocal microscopy images of A20 (left) or EL4 (right) cells that had been transiently transfected with GFP-cytoPKD. Representative
images are shown.
(D) FACS analysis of rCD2 cell surface staining of A20 (left) or EL4 (right) cells that had been transiently transfected with membPKD (open)
or empty vector control (Co, filled).
to control the fate of RAG2/DN3 cells was investigated in RAG2/ thymi made us query whether membPKD
promoted development of TCR null T cells on a wild-by analyzing thymi from RAG2/ membPKD mice for
total cellularity and the presence of thymic subsets (Fig- type background. To probe this issue further, we exam-
ined membPKD pre-T cells for expression of intracellularure 4).
MembPKD could induce substantial proliferation of TCR (Wilson et al., 1999). There was a clear subpop-
ulation of both NLC and membPKD DN3s that had suc-RAG pre-T cells (4.9 106  1.5 106 to 20 106  12
106; Figure 4A) but was not sufficient to fully reconstitute cessfully rearranged their TCR locus and expressed
ic TCR subunits (Figure 4C). In NLC DN4s, 88% ofthymocyte numbers to normal levels. In DN3, the pre-
TCR normally instructs cells to downregulate CD25, cells express ic TCR subunits. In the membPKD mice
there was a substantial percentage (46%) of DN4s thatupregulate CD2 and CD5 expression, and initiate ex-
pression of CD4 and CD8 (Azzam et al., 1998; Godfrey were TCR chain null. This would be consistent with
membPKD inducing DN4 transition of DN3s that hadet al., 1993; Kruisbeek et al., 2000; Michie and Zuniga-
Pflucker, 2002; Rodewald et al., 1993; von Boehmer et not productively rearranged their TCR locus. Note, DPs
from membPKD mice all expressed TCR complexesal., 1999). RAG2/ thymocytes thus are comprised
solely of DN3s with high levels of CD25 and low levels (Figure 3D), reflecting that membPKD DN4s that express
TCR have a selective advantage over those that do not.of CD2 or CD5 (Figure 4B). Expression of membPKD
in RAG2/ mice induced downregulation of CD25 and
upregulation of CD2 and CD5 (Figure 4B) and initiated Generation of T Cell-Specific Transgenic Mice
Expressing Cytosol Targeted Active PKDdifferentiation of DN3 to CD4/8 DPs. Signals from active
PKD at the membrane are thus sufficient to mimic pre- Cytosol restricted active PKD (cytoPKD) was expressed
in T cells of transgenic mice using the CD2-LCR (FiguresTCR signals and drive pre-T cell proliferation and differ-
entiation from DNs to DPs. 5A and 5B), and it was immediately seen that PKD activa-
tion in the cytosol had a striking impact on thymocyteThe ability of membPKD to drive DP development
Immunity
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ences were not due to founder line variation. Two
founder lines expressing membPKD were analyzed with
identical phenotypes. One of these lines had double the
level of membPKD than the other (see Supplemental
Figure S1 at http://www.immunity.com/cgi/content/full/
19/4/491/DC1). Mice expressing the highest levels of
membPKD were crossed to generate homozygotes, and
the resulting further 2-fold increase in surface levels of
active PKD had no impact on phenotype and did not
prevent TCR expression (Supplemental Figure S1). The
actions of membPKD are thus saturated. For cytoPKD,
three founder lines were analyzed, and a key point is
that one of these expressed very low levels of the active
PKD and considerably less active PKD than the
membPKD mice. In this line there was still a blockade
of TCR expression (Supplemental Figure S2).
Figure 2. PKD Is Expressed and Activated by the Pre-TCR in Early
PKD Regulates TCRChain Expression by ControllingT Cell Precursors
V to D-J Rearrangements at the TCR Locus(A) Schematic description of T cell development: HSP, hematopoi-
The absence of TCRs on thymocytes expressing cy-etic stem cell; DN, CD4 CD8 double-negative; DP, CD4 CD8 double-
positive; SP4 or 8, CD4 or CD8 single-positive. toPKD was striking. There are finely tuned mechanisms
(B) Western blot analysis of PKD expression in 30 g of cell lysate controlling TCR expression during T cell development.
of the indicated thymic subsets using pan-PKD antibodies. Productive rearrangements of a single TCR allele
(C) PKD activation in response to 2C11-mediated CD3 crosslinking allows DN3s to express a functional pre-TCR which
of RAG2/ thymocytes was monitored by Western blot analysis
then induces feedback signals to block further re-using pS916 antiserum (-P916, upper panel). Pan-PKD antiserum
arrangements of the second TCR allele (Khor and(-PKD, lower panel) shows PKD expression.
Sleckman, 2002; Kruisbeek et al., 2000; Michie and Zun-
iga-Pflucker, 2002; von Boehmer et al., 1999). This pro-
cess is termed allelic exclusion and ensures that eachdevelopment (Figure 5C). CytoPKD thymi had reduced
cell numbers and very few DP and SP thymocytes which T cell will express a TCR chain of a single specificity.
One explanation for the lack of TCRs in the cytoPKDwas emphasized by the lack of TCR complex expression
(Figure 5C). This phenotype was strikingly different from mice could be that cytoPKD mimics the pre-TCR-medi-
ated allelic exclusion signal and prematurely switchesthat seen in thymocytes expressing membPKD where
surface TCR expression was readily detected (Figure off  chain rearrangements. In this context, the cytoPKD
thymi looks like thymi that express the active src kinase3D). CytoPKD thymi did contain a population of cells
that were null for CD4 and surface TCR but expressed p56lck, an upstream regulator of PKD that is known to
mimic the pre-TCR and induce allelic exclusion (Perl-low levels of CD8 (Figure 5C, upper panels) correspond-
ing to intermediate single-positives (ISPs), a transitional mutter, 1995).
To probe this issue, cytoPKD pre-T cells were initiallystage in the developmental progression of DN cells to
DPs (Kruisbeek et al., 2000; Michie and Zuniga-Pflucker, analyzed for intracellular (ic) expression of TCR and
CD3 (Figures 6A and 6B). There is a clear subpopulation2002; von Boehmer et al., 1999).
The thymic phenotype of the cytoPKD mice was very of NLC DN3s that have rearranged their TCR locus and
express ic TCR subunits (Figure 6A, left panels). Thisdifferent from that of the membPKD mice. These differ-
Figure 3. Expression of Membrane Targeted
Active PKD in T Cells of Transgenic Mice
(A) Schematic of the human CD2 promoter
(HuCD2p) and locus control region (LCR)
used to express membrane targeted active
PKD (membPKD) in T cells of transgenic
mice. Arrows indicate the positions of trans-
gene-specific primers used in PCR-based
screening for transgene carrying mice.
(B) FACS analysis of rat CD2 cell surface ex-
pression of DN3 cells. Normal littermate con-
trol (NLC), filled; membPKD, open.
(C) Western blot analysis of nonstimulated ()
and PdBu stimulated () NLC or membPKD
total thymocytes with P916 antisera (-P916)
to monitor activity of the membPKD trans-
gene. Arrows indicate endogenous PKD (ePKD) and membPKD.
(D) Dot plots (upper panels) show CD4 and CD8 staining profiles of Thy1.2 NLC and membPKD thymocytes. Histograms (lower panels) show
TCR expression profiles of total Thy1.2 NLC and membPKD thymocytes. Numbers indicate cell numbers of Thy 1.2 NLC (n 	 12) and
membPKD (n 	 12) thymocytes.
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Figure 4. Membrane Targeted Active PKD
Promotes DN3 to DP Differentiation in the
Absence of Pre-TCR
(A) Numbers of Thy1.2 thymocytes in
RAG2/ (n 	 4), RAG2/ membPKD (n 	 5),
and RAG2/ membPKD (n 	 5) mice.
(B) Dot plots show CD4 and CD8 staining pro-
files, and histograms show CD25, CD2, and
CD5 expression in total Thy1.2 thymocytes
from RAG2/ and RAG2/ membPKD mice.
(C) Histograms show intracellular TCR stain-
ing in NLC and membPKD DN3 and DN4s.
Isotype-matched control antibody overlays
with the negative peaks in NLC DN3 and
membPKD DN3 and DN4s.
(D) Intracellular CD3 staining (filled histo-
grams) of NLC and membPKD DN3 and DN4
cells. Dotted lines show isotype-matched
control antibody staining.
subpopulation is absent from cytoPKD DN3s. Ic TCR  rearrangements intact (Uematsu et al., 1988). V to D2-
J2 rearrangements of the TCR gene were detectedstaining was also undetectable in cytoPKD DN4s com-
pared to NLC DN4s (Figure 6A, right panels). In contrast, using sense primers located within individual V seg-
ments (Vn) together with antisense primers downstreamboth cytoPKD DN3 and DN4 expressed ic CD3 at levels
comparable to NLC (Figure 6B). of J2.7 (J2) as schematically shown in Figure 6C (Gart-
ner et al., 1999). As the distance between the V andThe gene encoding a functional TCRchain is produced
by somatic recombination of V (variable), J (joining), and D-J segments in germline configuration (at least 250
kb) prevents amplification by PCR, only rearrangedD (diversity) gene segments at the TCR locus (Figure 6C)
(Khor and Sleckman, 2002). The rearrangement process V-D-J genes will give rise to a series of specific
bands corresponding to the individual J2 segmentsis ordered: D to J rearrangements precede V to
D-J rearrangements. If rearrangements do not occur, involved. D2 to J2 rearrangement is similarly detected
using a combination of sense D2 (D2) and antisensepre-T cells do not express TCR chains. The failed TCR
chain expression in cytoPKD DNs prompted us to as- J2 primers (Gartner et al., 1999).
V to D-J and D to J rearrangements were pres-sess the levels of V to D-J and J to D re-
arrangements in thymocytes from NLC and cytoPKD ent in NLC thymocytes but absent in RAG2/ thymo-
cytes (Figure 6D). Strikingly, TCR rearrangements inmice (Figure 6D). As controls, we analyzed RAG2/
thymocytes that lack one of the recombinases essential both total cytoPKD thymocytes and sorted cytoPKD
DN4 cells were nearly undetectable for four different Vfor the TCR gene recombination process and TCR
chain transgenic (TCR TG) thymocytes that are known families (V5, 8, 10, and 11), similar to what was seen
in the TCR TG control. In contrast, D2 to J2 re-to induce allelic exclusion and thus specifically prevent
V to D-J rearrangements while leaving D to J arrangements could be detected in NLC, cytoPKD, and
Figure 5. Lack of Mature T Cells in the Thy-
mus of Mice Expressing Cytosolic Active PKD
(A) Schematic picture of the HuCD2p/LCR
used to express a cytosolic active PKD (cy-
toPKD) in T cells of transgenic mice. Arrows
indicate the positions of transgene-specific
primers used in PCR-based screening for
transgene-carrying mice.
(B) Western blot analysis of nonstimulated
() and PdBu stimulated () NLC or cytoPKD
total thymocytes were performed to monitor
expression (-PKD, right panel) and activity
(-P916, left panel) of the cytoPKD transgene.
Arrows indicate endogenous PKD (ePKD)
and cytoPKD.
(C) Dot plots show CD4 and CD8 staining pro-
files, and histograms show TCR (upper pan-
els) and CD3
 (lower panels) expression pro-
files of total Thy 1.2 NLC and cytoPKD
thymocytes. Numbers indicate cell numbers
of Thy 1.2 NLC (n 	 21) and cytoPKD (n 	
21) thymocytes.
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ductively rearrange TCR chains would explain the lack
of TCR expression in cytoPKD thymocytes.
One question is whether the failure to make DPs and
SPs in the cytoPKD mice is due solely to the absence
of TCR subunits. One way to address this issue is to
examine whether expression of a TCR complex could
rescue DP and SP development in the cytoPKD mice.
Accordingly, cytoPKD was coexpressed with trans-
genes encoding the P14 TCR (Pircher et al., 1989) which
recognize the lymphocytic choriomeningitis virus (LCMV)
glycoprotein peptide presented by histocompatibility
complex (MHC) class I H-2 Db molecules. Expression of
cytoPKD did not prevent expression of the P14 trans-
genic TCR complexes, but the phenotype of the cy-
toPKD/P14 TCR transgenic mice was indistinguishable
from that of cytoPKD mice in terms of thymus size (Sup-
plemental Figure S4). Moreover, no DPs or SPs devel-
oped in the cytoPKD/TCR transgenic mice. Similarly,
expression of transgenes encoding the HY TCR complex
(Kisielow et al., 1988) did not restore thymocyte develop-
ment in the cytoPKD mice (data not shown).
CytoPKD Promotes DN3 to DN4 Transition
in the Absence of TCR Chains
Absence of TCR normally results in a block of T cell
development at the DN3 stage (Godfrey et al., 1994).
Strikingly, despite the lack of TCR expression, the cy-
toPKD thymi showed significant cell numbers (30–35
million), and CD8 ISPs were present. This prompted
us to analyze the cytoPKD DN compartment in detail.
CytoPKD thymi contained all four DN subsets but had
an unusual distribution of DN3 and DN4 cells (Figure
Figure 6. Cytosolic Active PKD Prevents TCR Chain Locus Re- 7A). There was an approximate 2-fold reduction of
arrangements CD25 cells with a corresponding 2-fold increase in
(A) Histograms show intracellular TCR staining in NLC and cytoPKD CD25 cells in cytoPKD thymi compared to NLC. As
DN3 and DN4. Isotype-matched control antibody overlays with the
well, cytoPKD DN3 cells appear shifted into a populationnegative peaks in NLC DN3 and cytoPKD DN3 and DN4.
transitional between the normal DN3 and DN4 stages(B) Intracellular CD3 staining (filled histograms) of NLC and cytoPKD
since levels of CD25 on CD25 cells are lower thanDN3 and DN4 cells. Dotted lines show isotype-matched control
antibody staining. normal (MFI 521 as compared to 831 in NLC; Figure 7A,
(C) Schematic representation of the TCR locus. Variable (V), diver- lower panels).
sity (D), joining (J), and constant (C) region segments are shown. DN3 to 4 transition is controlled by the pre-TCR which
Arrows show PCR primers used to amplify recombined products,
in DN3s stimulates an increase in cell size and inducesand the asterisk indicates a pseudogene (J2.6).
cell cycle progression (Hoffman et al., 1996). FACS for-(D) PCR analysis of TCR gene rearrangements in NLC, cytoPKD
ward side scatter (FSC) analysis indicated that cytoPKD(total thymocytes or sorted DN4s), TCR transgenic (TCR), or
RAG2/ mice. The indicated amounts of thymocyte genomic DNA DN3s are larger than normal (Figure 7B) and the percent-
were subjected to PCR using primers combinations detecting V8- age of cytoPKD DN3 cells in the proliferative (SG2/M)
J2, V10-J2, V11-J2, or D2-J2 rearrangements. V5-J2 phases of cell cycle was increased compared to NLC
PCR reaction gave similar results (data not shown). Fragments cor-
DN3s (Figure 7C). DN4s from normal thymi are typicallyresponding to the specific J2 fragments involved are shown to the
blastoid, highly proliferative cells. In contrast, cytoPKDleft in the top panel. Product specificity was confirmed by Southern
DN4 cells are smaller than NLC DN4s (Figure 7B) andblot hybridization using a J2.7-specific probe. The bracket in the
D2-J2 panel indicates rearranged D2-J2 fragments while the essentially all in the G0/G1 stage of the cell cycle as
top band represents the D2-J2 region in germline configuration. compared to highly proliferative NLC DN4s (Figure 7C).
C were amplified as a control for DNA template concentrations Pre-TCR signaling also induces upregulation of CD2 and
(IGM).
CD5 antigens (Azzam et al., 1998; Rodewald et al., 1993),
and it was seen that cytoPKD DN3 and DN4 cells have
upregulated expression of CD2 and CD5 (Figure 7B).TCR TG thymocytes. CytoPKD thus replicate the re-
arrangement defect of TCR TG mice. In contrast, DN4s DN3 cells in cytoPKD mice grow, proliferate, and prog-
ress to DN4 in the absence of TCR expression, whichfrom membPKD mice have  locus rearrangements in-
distinguishable from normal mice (Supplemental Figure supports the argument that activation of PKD in the
cytosol is sufficient for DN3 to DN4 progression in theS3). Taken together, analysis of TCR rearrangements
suggests that PKD activation in the cytosol prevents V absence of a functional pre-TCR. To test this hypothesis,
we expressed cytoPKD in RAG null thymocytes defec-to D-J rearrangements but allows D to J re-
arrangements. The failure of cytoPKD pre-T cells to pro- tive in antigen receptor rearrangements and thus unable
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Figure 7. Cytosolic Active PKD Promotes DN3 to DN4 Differentiation in the Absence of Pre-TCR
(A) Dot plots (upper panels) show CD44 and CD25 profiles of Thy1.2-positive, lineage-negative thymocytes from NLC and cytoPKD mice.
Histograms (lower panels) show CD25 expression in NLC and cytoPKD DN thymocytes defined as above. Mean fluorescence intensity (MFI)
for CD25 cells is shown in the histograms.
(B) Histogram overlays show FSC (size), CD2 and CD5 expression of NLC (filled), and cytoPKD (open) DN3 and DN4 cells.
(C) Histograms show cell cycle analysis of NLC and cytoPKD DN3 and DN4 cells stained with 7AAD to reveal cellular DNA content. Percentage
of cycling cells in the SG2M phases of cell cycle is shown in each histogram. Data in (A)–(C) are representative of  four mice.
(D) Cell numbers of Thy1.2 thymocytes in RAG1/ (n 	 8), RAG1/ cytoPKD (n 	 10), and RAG1/ cytoPKD (n 	 7) mice.
(E) Dot plots show CD4 and CD8 staining profiles, and histograms show CD25, CD2, and CD5 expression in total Thy1.2 thymocytes from
RAG1/ and RAG1/ cytoPKD mice.
to progress beyond the DN3 stage of thymocyte devel- common, but experimental analysis of the relevance of
opment (Godfrey et al., 1994; Mombaerts et al., 1992). changes in protein localization are rare. Accordingly, the
Expression of cytoPKD in RAG1/ thymi induced aim of the present work was to compare the actions of
marked proliferation of thymocytes as shown by the membrane and cytosol targeted active PKD. The current
large increase in cell numbers in RAG1/ cytoPKD work was carried out in pre-T cells of transgenic mice.
thymi over RAG1/ thymi (4–5  106 to 30–35  106; These cells are a good model for PKD functional studies
Figure 7D). CytoPKD induced downregulation of CD25 because they normally express PKD and activate it via
and upregulation of CD2 and CD5 in RAG1/ thymo- the pre-TCR. When expressed in recombinase null mice
cytes (Figure 7E). CytoPKD also initiated CD8 expres- that lack pre-TCRs, membrane targeted and cytosolic
sion, as judged by the appearance of ISPs (Figure 7E). active PKD induced a differentiation program reminis-
Hence, active cytosolic PKD was sufficient to promote cent of selection: downregulation of CD25 and upregu-
activation, proliferative expansion, and differentiation lation of CD2 and CD5. Moreover, membPKD and cy-
of RAG1/ DN3 cells. CytoPKD, unlike the membrane toPKD were both able to induce proliferation of T cell
targeted PKD, cannot induce T cells to differentiate to progenitors in the absence of the pre-TCR. There were,
DPs. The results in Figure 7 also show that the prolifera- however, two striking differences between the actions
tive effects of cytoPKD are cell context dependent: cy- of the differentially localized PKDs. First, the expression
toPKD can induce an increase in cell size and prolifera- of the CD8 and CD4 coreceptors in recombinase null
tion of DN3s but cannot do the same in DN4s. mice was only induced by PKD localized to the plasma
membrane and not by cytosolic PKD. Second, cytosolic
active PKD suppressed V to DJ rearrangements ofDiscussion
the TCR chain locus in pre-T cells and prevented ex-
pression of TCR chains, whereas active PKD at theIn the present report we explore whether a change in
membrane did not. The different actions of cytosolicthe intracellular location of PKD affects the biological
and membrane targeted PKD reveal that the function ofrole of the protein. PKD is activated exclusively by anti-
this kinase is determined by its intracellular location.gen receptors in lymphocytes (Matthews et al., 2000b)
The ability of cytoPKD to suppress TCR re-and is known to switch from the membrane to the cytosol
arrangements was reminiscent of allelic exclusion, aduring T cell activation (Matthews et al., 1999a, 2000a).
Descriptions of the location of signaling molecules are process whereby a negative feedback mechanism in-
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duced by the pre-TCR terminates V to D-J re- in the cytosol prevented DP generation in TCR trans-
arrangements (Khor and Sleckman, 2002; Kruisbeek genic mice. This would be consistent with a model
et al., 2000; Michie and Zuniga-Pflucker, 2002; von whereby cytosolic PKD negatively regulates TCR-medi-
Boehmer et al., 1999). In normal T cell development, ated responses. This hypothesis awaits further study
productive rearrangements of a single TCR allele by but what is striking about the ability of cytosolic PKD
the ordered assembly of V, D, and J gene segments to stop proliferation in DN4s is that this response is
occurs in DN2/3 cells. This allows pre-T cells to express cell context dependent. Hence, in DN3 pre-T cells the
a functional  chain which complexes with the invariant consequences of activating PKD in the cytosol are posi-
pre-T chain and the CD3 antigen to form a functional tive. TCR chain null DN3s are normally small, quies-
pre-TCR complex. The pre-TCR then signals to down- cent, noncycling cells (Godfrey et al., 1994), but expres-
regulate further TCR chain rearrangements to ensure sion of cytoPKD induced a marked increase in cell size
that each T cell expresses a TCR chain of single speci- (cell growth), cell cycle progression, and proliferative
ficity. It has been difficult to find molecules that can expansion. DN4s expressing cytoPKD were, in contrast,
mimic this action of the pre-TCR and terminate TCR small and could not enter the replicative phase of the
V to DJ rearrangements (Khor and Sleckman, 2002; cell cycle. CytoPKD could thus not substitute for the
Kruisbeek et al., 2000; Michie and Zuniga-Pflucker, pre-TCR and induce growth or cell cycle progression of
2002; von Boehmer et al., 1999), whereas there is a long DN4 cells. The cell context-dependent actions of cy-
list of molecules which regulate pre-T cell survival and toPKD as a growth factor and a mitogen versus a growth
proliferation but fail to induce allelic exclusion. These inhibitor must mean that there are differences in PKD
include guanine nucleotide binding proteins like Ras substrates and downstream signaling molecules in dif-
(Norment et al., 2003; Gartner et al., 1999), Rap1A (Seb- ferent T cell subsets. The present results thus show that
zda et al., 2002), RhoA (Corre et al., 2001), Rac-1 (Gomez PKD is not necessarily “hard-wired” to control a single
et al., 2000), and Cdc42 (Na et al., 1999). Moreover, biological response but has some plasticity that allows
expression of active serine kinases in pre-T cells such it to act as a molecular switch to control diverse re-
as Raf-1 and MAPK/ERK kinase (MEK) induces cell pro- sponses in different cell populations. The actions of PKD
liferation and differentiation while having no impact on are thus determined by the intracellular location of the
TCR chain rearrangements (Iritani et al., 1999). Pre- molecule, and this enzyme can act either as a positive or
TCR induced signaling pathways thus bifurcate with dis- negative regulator of T cells, depending on cell context.
tinct signals regulating differentiation and proliferation
Experimental Proceduresversus allelic exclusion (Gartner et al., 1999; Iritani et
al., 1999). The challenge has been to identify molecules
cDNA Constructs and Transgenic Micethat mediate the allelic exclusion process. PKD can al-
Detailed descriptions of cDNA constructs can be found in the Sup-most uniquely mimic the ability of the pre-TCR to termi-
plemental Data at http://www.immunity.com/cgi/content/full/19/4/
nate  chain rearrangements consistent with the idea 491/DC1. In brief, cytoplasmic active PKD was generated by fusing
that active cytosolic PKD is perceived by pre-T cells as the catalytic domain of PKD (aa 559–918) to the C-terminal of GFP
a signal that they express a functional TCR chain so or the myc epitope tag (MEQKLISEEDL). Membrane targeted active
PKD was generated by fusing the catalytic domain of PKD to thethe cells accordingly initiate the feedback mechanism
extracellular and transmembrane domains of rCD2. MembPKD orthat ensures allelic exclusion. The present results do
myc-tagged cytoPKD were subcloned into a transgenic expressionnot explore whether PKD is redundant in this function;
vector containing the promoter, the first intron, and the locus controlthis requires analysis of PKD knockouts which are as
region of the human CD2 gene (Zhumabekov et al., 1995). The re-
yet unavailable. Nevertheless, persuasive arguments for sulting plasmids were used to generate transgenic mouse lines fol-
the physiological relevance of the present results stem lowing standard protocols. Transgene-carrying mice were identified
from biochemistry which positions PKD in pre-TCR sig- by polymerase chain reaction of genomic DNA from mouse ear
punches. The primers used to identify the PKD part were TgPKD2,nal transduction pathways. PKD is also a downstream
5-GACTATCAGACCTGGTTAGATTTACG (sense); Tg PKD3, 5-GCCeffector of molecules known to be essential for the pro-
ATTGATCTTATCAATAACTTGC (sense); VAh4, 5-GGGGACAATGAcess of  selection such as p56lck, SLP76, and PKC
GTTTTCTGCTG-3, (antisense); and the primers used to identify the(Aifantis et al., 1999; Michie et al., 2001; Perlmutter, rCD2 part were VAh2, 5-GTCCCAACCCAGCTTTCCCTG-3 (sense);
1995). Moreover, the selectivity of the response trig- TgrCD2-1, 5-GCTGCACTCCCAGTAGATCATCGGC-3 (antisense).
gered by cytosolic and not membrane PKD in terms of Stable cytoPKD and membPKD transgenic lines were established
regulating  chain rearrangements is consistent with by backcrossing transgene-carrying founder mice with C57/BL6/J
mice. Rag1/ (Mombaerts et al., 1992), Rag2/ (Shinkai et al.,spatial/temporal aspects of PKD activity: PKD is found
1992), P14 TCR (Pircher et al., 1989), and HY TCR (Kisielow et al.,in the cytosol during sustained responses and it is at this
1988) transgenic mice have been previously described. Mice weretime that the cell would be expected to initiate negative
bred and maintained under pathogen-free conditions in the Cancer
feedback mechanisms such as the process of allelic ex- Research UK Biological Resources Unit.
clusion.
MembPKD and cytoPKD were equivalent in their abil- Cell Stimulation and Western Blots
ity to induce DN3 to DN4 transition and proliferation of Thymocyte preparation and transient transfection of A20 and EL4
cell lines were as described (Gomez et al., 2000; Matthews et al.,T cell progenitors in recombinase gene null mice, but
2000a). To monitor PKD activity, cells were stimulated with mediumtransition to CD4/CD8 DPs was only triggered by mem-
alone or 20 ng/ml PdBu for 8 min at 37C. Total RAG2/ thymocytesbrane targeted PKD. The absence of DPs in cytoPKD
were stimulated by plating onto immobilized CD3 crosslinking
mice seemed to be explained by failure of DN4s to prog- monoclonal antibody 2C11 (50 g/ml) for 20–60 min at 37C. Stimu-
ress rather than production and then deletion of DPs lated cells were washed in ice-cold phosphate-buffered saline (PBS)
because DN4s expressing cytoPKD were abnormally and lysed at 20  106 cells/ml in buffer (100 mM HEPES [pH 7.4],
150 mM NaCl, 1% NP40, 20 mM sodium fluoride, 20 mM Iodoacet-small and nonproliferative. Moreover, activation of PKD
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amide, 2 M EDTA, 1 mM sodium orthovanadate, 2 g/ml pepstatin DNA from TCR transgenic mice was obtained from OT-I transgenic
mice (Jackson Laboratories, Bar Harbor, ME; stock number 002929).A, 2 g/ml leupeptin, 2 g/ml chymostatin, 2 g/ml antipain, 40
mM -glycerophosphate, and 1 mM phenylmethylsulfonylfluoride).
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